News and Articles

ROX Medical Enrolls First Patient in Randomized Controlled Hypertension Trial of AV-Coupler

ROX Medical announced the first patient enrollment in the CONTROL-HTN international randomized controlled trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood pressure). The first patient was enrolled at the Universitair Ziekenhuis Brussel (University Hospital of Brussels) Brussels, Belgium by Professor Danny Schoors and Dr Sofie Brouwers. Read Study Here

roxmedicalusROX Medical Enrolls First Patient in Randomized Controlled Hypertension Trial of AV-Coupler
read more

Dr. Sofie Brouwers presents the ROX COPD/HTN data at Austin Doyle Award Session at ISH 2012, Sydney, Australia

Dr. Sofie Brouwers from UZ Brussel, Belgium was selected to present at the prestigious Austin Doyle Award Session during the 2012 International Symposium of Hypertension (ISH) in Sydney, Australia. Dr. Brouwers presented the 12-month data from the ROX Medical US IDE and German Multicenter study on patients with concomitant COPD and Hypertension. The resulting data

roxmedicalusDr. Sofie Brouwers presents the ROX COPD/HTN data at Austin Doyle Award Session at ISH 2012, Sydney, Australia
read more

ROX Medical Announces First Clinical Use of the ROX FLOW Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients

ROX Medical, Inc. today announced the first clinical use of the ROX COUPLER TM at the Universitair Ziekenhuis Brussel (University Hospital of Brussels) to treat resistant hypertension. “We are pleased to have performed the first ever ROX FLOW Procedure for this new approach to hypertension, the acute impact on the patients’ blood pressure was greater

roxmedicalusROX Medical Announces First Clinical Use of the ROX FLOW Procedure for the Treatment of High Blood Pressure in Resistant Hypertension Patients
read more